boaz Sagi
- 4.4 Good • 148 reviews
- 35 years of experience
- Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
Professor Shlomi Constantini is a highly-trained neurosurgeon in Israel with expertise in general and pediatric neurosurgery, microsurgical operations, reconstructive interventions, and brain and spine tumor treatments. He has received several awards and is a member of multiple professional organizations.
20 top ranked Oncology doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Oncology doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Oncology doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Oncology varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Oncology if you have any difficulties with a choice. Bookimed services are free for patients ♥
Professor, Oncologist
Professor Dan Grisaro is a leading Israeli specialist in gynecological cancer diagnosis and treatment, specializing in ovarian cancer, uterine cancer, and cervical cancer. He has senior physician, head of department and lecturer experience at various medical centers and universities. He has held 39 presentations and is the author of 83 published scientific articles, and is a member of various professional societies.
Prof. Jack Baniel is a Professor of Urology and Chief of Urology section at Rabin Medical Center, Petach Tikva, Israel. He specializes in the reconstruction of the bladder, robotic prostatectomy, cancer surgeries with preservation of the nerve endings. He has published over 100 scientific articles and is actively involved in research in the field of uro-oncology. He is a graduate of Tel Aviv University and is a member of various professional organizations, including the Israeli Medical Association, the Israeli Association of Urology, the European Association of Urology, the European Organization for Research and Treatment of Cancer (EORTC), and the American Association of Urology.
Education/Residency:
Dr. Tatyana Rabin's research interests include:
Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,
study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;
clinical studies of oncomammology, oncopulmonology, ocular lymphoma.
Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.
In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.
Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.
Awards:
Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.
Experience and participation in scientific research:
Membership in medical societies :
Education
Faculty of Medicine: Sackler Faculty of Medicine, Tel Aviv University
Specialization
Institute of Oncology, Davydov Center, Beilinson Hospital
Recognized experience
Medical Oncology and Radiation Therapy
Additional education
Department of Radiation Therapy, Duke University Medical Center, USA
Clinical experience
Attending conferences
About 15 professional publications
Trade union membership
Areas of special interest and activities
Cerebral metastases and primary brain tumors, head and neck tumors, radiation therapy and radiosurgery
Dr. Sternheim Amir is an experienced orthopaedic surgeon. He specializes in orthopaedic oncology, joint replacement, and complex hip and knee reconstruction. He is known for using advanced 3D technology and computer-assisted methods. These tools help him plan surgeries with high precision, especially for predicting femur fractures in patients with metastatic disease.
Dr. Amir has published many research papers and has spoken at major medical conferences. His main interests are sarcoma and metastatic bone cancer. He has received several awards, such as the Outstanding Resident Award at Tel-Aviv Medical Center. He has also earned grants from the Israeli Cancer Society and the University of Toronto. Dr. Amir is an active member of MSTS, CTOS, and ISOLS, which shows his strong reputation in the field.
Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.
This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.
Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the bone marrow and kidneys, destroying the tumor from the inside.
In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!
All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.
Education
2000-1994 Faculty of Medicine in Vitebsk, Belarus.
Specialization
2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.
Recognized experience
Oncology and radiation therapy
Additional education
2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors
Attending conferences
About 10 presentations at medical conferences
Trade union membership
Oncology:
Head and neck tumors
Thyroid cancer
Personalized biological and immunotherapy
Treatment of recurrent cancer and spinal metastases
Radiotherapy
1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).
1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.
1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).
Authored numerous peer-reviewed articles in scientific journals. Selected topics include:
Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.
TP53 missense mutation recurrence in cancer patients of Arab descent.
Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.
Prognostic significance of (R)CA15-3 assay in primary breast cancer.
Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.
Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.
Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.
Israeli Society of Clinical Oncology
Israel Medical Association
Cancer Genetics Research Foundation Award
Landau Prize
Judith Segal Memorial Award
Dr. Victoria Neiman is a renowned oncologist, mammologist, and oncourologist with 25 years of professional experience and extensive international experience. She specializes in the treatment of urological malignant tumors, breast cancer, oncourology, and chemotherapy. She heads the oncological surgery department at Rabin Medical Center and is a member of multiple oncology societies.
Oncogynecologist. Specialist in minimally invasive surgeries
Prof. Peled is a leading specialist in lung cancer immunotherapy, with expertise in Internal Medicine, Pulmonology and Medical Oncology. He has received the ASCO Merit Award, and is the head of the Thoracic Cancer Unit at Davidoff Cancer Center and Head of the Research and Detection Unit for Thoracic malignancies at Sheba Medical Center. He is a member of the Thoracic Oncology Assembly of the European Respiratory Society and Chair of the Early Detection and Prevention Committee of the International Association for the Study of Lung Cancer.
Urologist, Surgeon